Researchers can now order their mutation of choice in bit.bio’s opti-ox TM powered human-iPSC derived cells, receiving consistent, defined, cryopreserved products that can be immediately incorporated ...

Immorta Bio Inc. has reported new data demonstrating that its combination therapy of Senovax, a first-in-class senolytic immunotherapy, and personalized mesenchymal stem cells (pMSCs) from its ...

Alana Welm (left) is the Senior Director of Basic Science at the Huntsman Cancer Institute (University of Utah, UT, USA). Her lab studies breast cancer and its metastasis – the main cause of death for ...